The Finnish experience to save asthma costs by improving care in

Slides:

Advertisements

Similar presentations

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,

Advertisements

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.

Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.

Severe adult-onset asthma: A distinct phenotype

Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort Mikael Kuitunen, MD, PhD, Kaarina.

D-dimer: A biomarker for antihistamine-resistant chronic urticaria

Leena von Hertzen, PhD, Tari Haahtela, MD, PhD

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial Kaarina.

Information technology–based approaches to reducing repeat drug exposure in patients with known drug allergies Kathrin M. Cresswell, MSc, Aziz Sheikh,

Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O

Fatty acids, inflammation, and asthma

Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: A longitudinal analysis Rafael Pasternack, MD, PhD, Heini Huhtala, MSc, Jussi Karjalainen,

Information technology–based approaches to reducing repeat drug exposure in patients with known drug allergies Kathrin M. Cresswell, MSc, Aziz Sheikh,

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD

Ann-Marie M. Schoos, MD, PhD, Jacob D

Ophthalmologic findings in children with asthma receiving inhaled budesonide Anna Pelkonen, MD, PhD, Osmo Kari, MD, PhD, Olof Selroos, MD, PhD, Kurt Nikander,

Applying epidemiologic concepts of primary, secondary, and tertiary prevention to the elimination of racial disparities in asthma Christine L.M. Joseph,

Incident asthma and Mycoplasma pneumoniae: A nationwide cohort study

Is 9 more than 2 also in allergic airway inflammation?

Desensitization to Chemotherapeutic Agents

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

Fatty acids, inflammation, and asthma

Hospitalization rates and prognosis of patients with anaphylactic shock in Denmark from 1995 through 2012 Anni Nørgaard Jeppesen, MD, Christian Fynbo.

Rising prevalence of asthma is sex-specific in a US farming population

Advancing asthma care: The glass is only half full!

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Katherine A. Vierk, MPH, Kathleen M. Koehler, PhD, MPH, Sara B

The National Biome Initiative: An allergy perspective

Physician needs in health informatics: Just ask the docs

Peter M. Wolfgram, MD, David B. Allen, MD

Etiology of asthma exacerbations

William J. Calhoun, MD, Tmirah Haselkorn, PhD, Dave P

Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O

Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA

Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes Anick Bérard, MSc, PhD, Odile Sheehy, MSc, Marie-Laure Kurzinger,

Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation Leif Bjermer, MD Journal of Allergy.

Food allergy in patients with primary immunodeficiency diseases: Prevalence within the US Immunodeficiency Network (USIDNET) Karen S. Tuano, MD, Jordan.

Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management Scott H. Sicherer, MD, Hugh A. Sampson, MD Journal.

Biosimilars and drug development in allergic and immunologic diseases

Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A

News Beyond Our Pages Journal of Allergy and Clinical Immunology

A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,

Claus Bachert, MD, PhD, Cezmi A. Akdis, MD

What is an “eosinophilic phenotype” of asthma?

Medication use in children with asthma in Finland from 1995 to 2006

H. William Kelly, PharmD Journal of Allergy and Clinical Immunology

Autophagy: Nobel Prize 2016 and allergy and asthma research

Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment

Advances in the approach to the patient with food allergy

Geographic variability in childhood asthma prevalence in Chicago

A single intervention for cockroach control reduces cockroach exposure and asthma morbidity in children Felicia A. Rabito, PhD, MPH, John C. Carlson,

Mary F. Linehan, PhD, Timothy L. Frank, MD, Michelle L

Leena von Hertzen, PhD, Tari Haahtela, MD, PhD

Risk of oral food challenges

Benjamin Chaigne, MD, Hervé Watier, MD, PhD

Association between climate factors, pollen counts, and childhood hay fever prevalence in the United States Jonathan I. Silverberg, MD, PhD, MPH, Marc.

Acid-suppressive drug use in pregnancy and the toddler's asthma risk: A crossover, case-control study Bianca Mulder, BSc, Catharina Carolina Maria Schuiling-Veninga,

Measles and immunomodulation

Atopic endotype in childhood

Severity assessment in asthma: An evolving concept

Macrolide antibiotics and asthma treatment

Asthma: The past, future, environment, and costs

Environmental factors and eosinophilic esophagitis

Natural history of cow’s milk allergy

Primary prevention of asthma and allergy

Itching as a systemic disease

Presentation transcript:

The Finnish experience to save asthma costs by improving care in 1987-2013 Tari Haahtela, MD, Fredrik Herse, MSc, Jussi Karjalainen, MD, Timo Klaukka, MD, Miika Linna, PhD, Riikka-Leena Leskelä, PhD, Olof Selroos, MD, Eeva Reissell, MD Journal of Allergy and Clinical Immunology Volume 139, Issue 2, Pages 408-414.e2 (February 2017) DOI: 10.1016/j.jaci.2016.12.001 Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Overall annual costs of asthma care at the societal level in Finland from 1987 to 2013. Journal of Allergy and Clinical Immunology 2017 139, 408-414.e2DOI: (10.1016/j.jaci.2016.12.001) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Overall annual costs of asthma care at the patient level in Finland from 1987 to 2013. Journal of Allergy and Clinical Immunology 2017 139, 408-414.e2DOI: (10.1016/j.jaci.2016.12.001) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Actual (realized) annual expenditures of asthma care (blue columns) and minimum (red columns) and maximum (gray columns) scenarios of theoretic annual costs. The minimum scenario represents a theoretic annual expenditure if all of the 3-fold increase in prevalence was caused by patients with mild asthma. The maximum scenario assumes that the disease severity and standard of care remained at the 1987 level. The green line represents the percentage of patients receiving ICS medication. Journal of Allergy and Clinical Immunology 2017 139, 408-414.e2DOI: (10.1016/j.jaci.2016.12.001) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions